(adsbygoogle = window.adsbygoogle || []).push({});

NIMML Institute’s TITAN-X A.I.-Powered Precision Medicine Platform Validated through AbbVie’s Acquisition of Landos Biopharma and Lead Clinical Candidate NX-13

BLACKSBURG, Va.--(BUSINESS WIRE)--The NIMML Institute (“NIMML”), a 501 (c)(3) nonprofit institute dedicated to the discovery of novel precision medicines for autoimmune diseases, today recognized its…

Continue ReadingNIMML Institute’s TITAN-X A.I.-Powered Precision Medicine Platform Validated through AbbVie’s Acquisition of Landos Biopharma and Lead Clinical Candidate NX-13
Enjoying Merger Arbitrage Limited?

Enjoying Merger Arbitrage Limited?

Sign up then! It's quick and FREE

Have time to share an article? It's very much appreciated!!

You have Successfully Subscribed!